SEOM clinical guidelines for the management of adult soft tissue sarcomas

Clinical and Translational Oncology

Volumn 14, Issue 7, 2012, Pages 541-544

  García Del Muro Solans, Xavier ^a   Martín Broto, Javier ^b   Lianes Barragán, Pilar ^c   Cubedo Cervera, Ricardo ^d  

^a HOSPITAL DURAN I REYNALS   (Spain)

^b HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^c HOSPITAL DE MATARÓ   (Spain)

^d HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

Clinical guidelines; Soft tissue sarcoma

Indexed keywords

DOCETAXEL; DOXORUBICIN; GEMCITABINE; IFOSFAMIDE; IMATINIB; MELPHALAN; PACLITAXEL; PAZOPANIB; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT TUMOR NECROSIS FACTOR; TRABECTEDIN;

ADJUVANT CHEMOTHERAPY; ADULT; ADVANCED CANCER; ANGIOSARCOMA; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CLINICAL ASSESSMENT; CLINICAL PROTOCOL; CYTOLOGY; DERMATOFIBROSARCOMA PROTUBERANS; DRUG CONTRAINDICATION; DRUG MEGADOSE; DRUG TREATMENT FAILURE; FASCIA; HISTOLOGY; HUMAN; LEIOMYOSARCOMA; LONG TERM SURVIVAL; MEDICAL SOCIETY; MESENCHYME CELL; MYXOSARCOMA; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIATION DOSE; SOFT TISSUE SARCOMA; SYNOVIAL SARCOMA; TREATMENT INDICATION; TUMOR DIAGNOSIS; TUMOR LOCALIZATION; TUMOR VOLUME; UTERUS MYOMA;

ADULT; ALGORITHMS; DECISION TREES; HUMANS; MEDICAL ONCOLOGY; NEOPLASM METASTASIS; NEOPLASM STAGING; PRACTICE GUIDELINES AS TOPIC; SARCOMA; SPAIN;

EID: 84864711525     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-012-0838-7     Document Type: Article

References (12)

1. Bhangu AA, Beard JA, Grimer RJ (2004) Should soft tissue sarcomas be treated at a specialist centre? Sarcoma 8:1-6
2. O'Sullivan B, Davis AM, Turcotte R et al (2002) Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet 359:2235-2241
3. Pervaiz N, Colterjohn N, Farrokhyar F et al (2008) A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer 113:573-581
4. Frustaci S, Gherlinzoni F, De Paoli A et al (2001) Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. J Clin Oncol 19:1238-1247
5. Issels RD, Lindner LH, Verweij J et al (2010) Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol 11:561-570
6. Kim S, Ott HC, Wright CD et al (2011) Pulmonary resection of metastatic sarcoma: prognostic factors associated with improved outcomes. Ann Thorac Surg 92:1780-1786; discussion 1786-1787
7. Maurel J, Lopez-Pousa A, de Las Penas R et al (2009) Efficacy of sequential high-dose doxorubicin and ifosfamide compared with standard-dose doxorubicin in patients with advanced soft tissue sarcoma: an open-label randomized phase II study of the Spanish group for research on sarcomas. J Clin Oncol 27:1893-1898
8. Demetri GD, Chawla SP, von Mehren M et al (2009) Efficacy and safety of trabectedin in patientswith advanced or metastatic liposarcomaor leiomyosarcoma after failure of prior anthracyclinesand ifosfamide: results of a randomized phase II study of two different schedules. J ClinOncol 27:4188-4196
9. Garcia-Del-Muro X, Lopez-Pousa A, Maurel J et al (2011) Randomized phase II study comparing gemcitabine plus dacarbazine versus dacarbazine alone in patients with previously treated soft tissue sarcoma: a Spanish Group for Research on Sarcomas study. J Clin Oncol 29:2528-2533
10. Maki RG, Wathen JK, Patel SR et al (2007) Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected]. J Clin Oncol 25:2755-2763
11. Verweij J, Baker LH (2010) Future treatment of soft tissue sarcomas will be driven by histological subtype and molecular aberrations. Eur J Cancer 46:863-868
12. McArthur GA, Demetri GD, van Oosterom A et al (2005) Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225. J Clin Oncol 23:866-873